Cargando…
Novel Biomarkers of Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a highly prevalent condition worldwide. It represents one of the most common complications arising from diabetes mellitus (DM) and is the leading cause of end-stage kidney disease (ESKD). Its development involves three fundamental components: the hemodynamic, metabol...
Autores principales: | Rico-Fontalvo, Jorge, Aroca-Martínez, Gustavo, Daza-Arnedo, Rodrigo, Cabrales, José, Rodríguez-Yanez, Tomás, Cardona-Blanco, María, Montejo-Hernández, Juan, Rodelo Barrios, Dairo, Patiño-Patiño, Jhonny, Osorio Rodríguez, Elber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135955/ https://www.ncbi.nlm.nih.gov/pubmed/37189380 http://dx.doi.org/10.3390/biom13040633 |
Ejemplares similares
-
Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations”
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022) -
Molecular Mechanisms of Diabetic Kidney Disease
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022) -
Insulin and the kidneys: a contemporary view on the molecular basis
por: Daza-Arnedo, Rodrigo, et al.
Publicado: (2023) -
Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review
por: Daza-Arnedo, Rodrigo, et al.
Publicado: (2021) -
Hipercapnia refractaria en paciente con síndrome de obesidad-hipoventilación maligno y COVID-19. Reporte de caso y propuesta de manejo
por: Algarin-Lara, Holmes, et al.
Publicado: (2022)